Latest stories on VOR
Vor Biopharma Adds Industry Veteran David Zaccardelli to Board
TipRanks56 · neutralgeneral
Vor Biopharma Inc. (VOR) files 8-K
SEC 8-K50 · neutralgeneral
Vor Bio Appoints David Zaccardelli to Board of Directors | VOR Stock News
StockTitan59 · neutralgeneral
Vor Biopharma: A Financed Autoimmune Pivot With More Substance Than The Market Realizes
Seeking Alpha63 · neutralproduct/pr
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | VOR Stock News
StockTitan50 · neutralgeneral
Vor Biopharma Inc. (VOR) files 8-K
SEC 8-K50 · neutralgeneral
Vor Bio gains boost from telitacicept IgA nephropathy approval
TipRanks73 · bullishproduct/pr
Vor Biopharma Inc. (VOR) files 8-K
SEC 8-K50 · neutralgeneral
Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China | VOR Stock News
StockTitan71 · bullishproduct/pr
Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China | VOR Stock News
StockTitan71 · bullishproduct/pr
Vor Biopharma’s Phase 3 Sjögren’s Trial Puts Telitacicept on Investors’ Radar
TipRanks63 · neutralproduct/pr
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | VOR Stock News
StockTitan47 · neutralgeneral
Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference | VOR Stock News
StockTitan56 · neutralgeneral